All Donald Ingber articles
-
NewsWyss Institute selected to develop biologically engineered broad-spectrum antimicrobial therapeutic
The Wyss Institute for Biologically Inspired Engineering at Harvard University received a contract for up to $12M from the new SHIELD program which aims to develop a prophylactic treatment that can rapidly clear multiple bloodborne bacterial and fungal pathogens.
-
NewsHuman cervix modeled in microfluidic organ chip helps target bacterial vaginosis
Engineered cervix with in vivo-like mucus production, hormone sensitivity, and associated microbiome creates novel testbed for bacterial vaginosis therapeutics and other treatments.
-
NewsPathogen capture method speeds up ID in children with bloodstream infections
Researchers have developed a fast and highly efficient engineered pathogen capture method which shortcuts the accurate detection of pathogens in small blood samples, potentially saving lives.
